Smilow Cancer Hospital expert explains five things you need to know about Lung Cancer

Roy Herbst, M.D., Ph.D., chief of Medical Oncology at Smilow Cancer Hospital, has been researching lung cancer and treating patients with the disease for more than 25 years. He discusses the facts about lung cancer, ways to reduce your risk, and how...
4-Nov-2019 2:05 PM EST Add to Favorites

Yale Cancer Center study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer survival time, according to a new global study led by Yale Cancer Center (YCC).
30-Oct-2019 10:15 AM EDT Add to Favorites

Scientists build genomic research platform to help treat cervical cancer

Yale Cancer Center scientists have built a powerful genomic research platform to study cervical cancer, a disease that often is untreatable if it progresses after surgery or primary chemo-radiation treatment.
17-Oct-2019 4:35 PM EDT Add to Favorites

Researchers show genetic mutations in advanced lung cancer may predict improved outcomes

According to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC).
27-Sep-2019 12:00 PM EDT Add to Favorites

Yale Cancer Center Research Highlighted at ASTRO 2019

Yale Cancer Center (YCC) scientists presented research at the 61st annual American Society for Radiation Oncology (ASTRO) annual meeting in Chicago.
17-Sep-2019 6:00 PM EDT Add to Favorites

Adding Radiation After Immunotherapy Improves Survival Time for Patients with Advanced Lung Cancer

The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time for patients with metastatic non-small-cell lung cancer (NSCLC).
17-Sep-2019 3:55 PM EDT Add to Favorites

Yale Cancer Center finding offers hope for treatment of incurable Childhood Brain cancer

A team of investigators at Yale Cancer Center (YCC) have found a major chink in the armor of an incurable childhood brain cancer called Diffuse Intrinsic Pontine Gliomas (DIPG).
22-Aug-2019 11:10 AM EDT Add to Favorites

Yale Cancer Center researchers demonstrate novel drug increased survival for patients with bladder cancer.

There are no approved treatment options for patients with advanced bladder cancer after standard chemotherapy and immune treatments, but the results of a phase II clinical trial led by Yale Cancer Center and Smilow Cancer Hospital researchers...
3-Jun-2019 7:30 AM EDT Add to Favorites

see all news